495 related articles for article (PubMed ID: 25701309)
1. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
D'Souza AA; Devarajan PV
J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
Sakashita M; Mochizuki S; Sakurai K
Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
[TBL] [Abstract][Full Text] [Related]
3. Tailored Presentation of Carbohydrates on a Coiled Coil-Based Scaffold for Asialoglycoprotein Receptor Targeting.
Zacco E; Hütter J; Heier JL; Mortier J; Seeberger PH; Lepenies B; Koksch B
ACS Chem Biol; 2015 Sep; 10(9):2065-72. PubMed ID: 26057877
[TBL] [Abstract][Full Text] [Related]
4. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
[TBL] [Abstract][Full Text] [Related]
5. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Thapa B; Kumar P; Zeng H; Narain R
Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
[TBL] [Abstract][Full Text] [Related]
6. Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor.
Huang X; Leroux JC; Castagner B
Bioconjug Chem; 2017 Feb; 28(2):283-295. PubMed ID: 27966887
[TBL] [Abstract][Full Text] [Related]
7. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
[TBL] [Abstract][Full Text] [Related]
9. Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation.
Warrier DU; Dhanabalan AK; Krishnasamy G; Kolge H; Ghormade V; Gupta CR; Ambre PK; Shinde UA
Int J Biol Macromol; 2022 May; 207():683-699. PubMed ID: 35248606
[TBL] [Abstract][Full Text] [Related]
10. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
11. A polycation scaffold presenting tunable "click" sites: conjugation to carbohydrate ligands and examination of hepatocyte-targeted pDNA delivery.
Lee CC; Grandinetti G; McLendon PM; Reineke TM
Macromol Biosci; 2010 Jun; 10(6):585-98. PubMed ID: 20480507
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
13. Lectin recognition and hepatocyte endocytosis of GalNAc-decorated nanostructured lipid carriers.
Gauthier L; Chevallet M; Bulteau F; Thépaut M; Delangle P; Fieschi F; Vivès C; Texier I; Deniaud A; Gateau C
J Drug Target; 2021 Jan; 29(1):99-107. PubMed ID: 32936032
[TBL] [Abstract][Full Text] [Related]
14. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
Rensen PC; Sliedregt LA; Ferns M; Kieviet E; van Rossenberg SM; van Leeuwen SH; van Berkel TJ; Biessen EA
J Biol Chem; 2001 Oct; 276(40):37577-84. PubMed ID: 11479285
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate-based materials for targeted delivery of drugs and genes to the liver.
Ahmed M; Narain R
Nanomedicine (Lond); 2015 Jul; 10(14):2263-88. PubMed ID: 26214359
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
Nie H; Liu XM; Yang QX; Luo XD; Zhao Y; Zhang SY
Int J Pharm; 2022 Aug; 624():121967. PubMed ID: 35777585
[TBL] [Abstract][Full Text] [Related]
17. Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles.
D'Souza AA; Jain P; Galdhar CN; Samad A; Degani MS; Devarajan PV
AAPS J; 2013 Jul; 15(3):696-706. PubMed ID: 23580183
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
19. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
[TBL] [Abstract][Full Text] [Related]
20. Electrochemical evidence for asialoglycoprotein receptor--mediated hepatocyte adhesion and proliferation in three dimensional tissue engineering scaffolds.
Vasanthan KS; Sethuraman S; Parthasarathy M
Anal Chim Acta; 2015 Aug; 890():83-90. PubMed ID: 26347169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
